Dermavant focuses on innovative treatments for chronic skin conditions, leveraging scientific breakthroughs and advancing the standard of care in immuno-dermatology. The company is dedicated to improving patients' lives through targeted therapies and cutting-edge research in the biotechnology and pharmaceutical sectors.
Specialties
Innovative immuno-dermatology treatments
Topical therapies for plaque psoriasis
Arylhydrocarbon receptor agonist research
Targeted therapies for chronic skin conditions
Breakthrough science in biotechnology
Products & Services
Topical Treatments for Psoriasis
Immuno-Dermatology Innovations
Research and Development Services
Chronic Skin Condition Therapies
Patient Support Programs
Contact Information
No contact information available
Competitors & Similar Companies(6)
Amgen
California, • United States
Regeneron Pharmaceuticals
New York, • United States
Galderma
Vaud, • Switzerland
Incyte Corporation
Delaware, • United States
Valeant Pharmaceuticals (now Bausch Health)
Quebec, • Canada
Aesthetics Biomedical
Arizona, • United States • Industrial Products
News & Media
Search Terms:
dermavantdermavant sciences
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Dermavant belongs to the Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Dermavant?
Dermavant specializes in Innovative immuno-dermatology treatments, Topical therapies for plaque psoriasis, Arylhydrocarbon receptor agonist research, Targeted therapies for chronic skin conditions, Breakthrough science in biotechnology.
What products and services is Dermavant likely to offer?
Dermavant offers Topical Treatments for Psoriasis, Immuno-Dermatology Innovations, Research and Development Services, Chronic Skin Condition Therapies, Patient Support Programs.
Who are the competitors of Dermavant?
Competitors of Dermavant are Amgen, Regeneron Pharmaceuticals, Galderma, Incyte Corporation, Valeant Pharmaceuticals (now Bausch Health), Aesthetics Biomedical.
What does Dermavant do?
Dermavant focuses on innovative treatments for chronic skin conditions, leveraging scientific breakthroughs and advancing the standard of care in immuno-dermatology. The company is dedicated to improving patients' lives through targeted therapies and cutting-edge research in the biotechnology and pharmaceutical sectors.